Literature DB >> 31938222

In vivo evaluation of bronchial injury of irreversible electroporation in a porcine lung ablation model by using laboratory, pathological, and CT findings.

Jun-Hui Sun1,2,3,4, Tong-Yin Zhu1,2,3,4, Xin-Hua Chen1,2,3,4, Chun-Hui Nie1,2,3,4, Zhi-Gang Ren5, Guan-Hui Zhou1,2,3,4, Tan-Yang Zhou1,2,3,4, Sheng-Yong Yin1,2,3,4, Zhi-Yi Peng1,2,3,4, Li-Ming Wu1,2,3,4, Xiong-Xin Zhang2,3,4, Wei-Lin Wang1,2,3,4, Shu-Sen Zheng1,4.   

Abstract

Irreversible electroporation (IRE) creates permanent pores in the cell membrane, leading to irreversible cell death. In this study, the impact of IRE on bronchial injury was comprehensively examined in a timed series study. Altogether, 8 Bama miniature pigs were included in this study and were randomly assigned to experimental and control groups. The experimental group underwent IRE that was guided and monitored by spiral computed tomography (CT). The monopole probe of the IRE was positioned at the right pulmonary hilum. Specimens were collected at 0 h, 2 h, 2 d, 7 d, and 14 d after the IRE procedure for a pathological examination. A small amount of needle-tract bleeding occurred in two animals, and mild pneumothorax occurred in another. IRE can elicit acute bronchial inflammation, bleeding, and mucosal injury, but severe complications were not found. Pathological examinations and transmission electron microscopy (TEM) showed dead vascular epithelium cells in the region of the ablation, while the bronchioli and the vascular extracellular matrix were preserved. At 2 hours post-IRE, there were marked increases in bronchoalveolar macrophages (P<0.001), but the inflammation could recover after 14 days and showed no statistical significance when compared with the control group at the same time. In conclusion, CT-guided IRE ablation can elicit acute but recoverable bronchial inflammation, bleeding, and mucosal injury in porcine lung tissues. However, longer follow-up is still required to establish an evaluation of the long-term safety. IJCEP
Copyright © 2018.

Entities:  

Keywords:  Lung ablation; bronchial injury; computed tomography (CT); irreversible electroporation; porcine model; transmission electron microscopy (TEM)

Year:  2018        PMID: 31938222      PMCID: PMC6958169     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

1.  Angiography in the isolated perfused kidney: radiological evaluation of vascular protection in tissue ablation by nonthermal irreversible electroporation.

Authors:  Johann Jakob Wendler; Maciej Pech; Simon Blaschke; Markus Porsch; Andreas Janitzky; Matthias Ulrich; Oliver Dudeck; Jens Ricke; Uwe-Bernd Liehr
Journal:  Cardiovasc Intervent Radiol       Date:  2011-06-02       Impact factor: 2.740

2.  Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies.

Authors:  Kee-Min Yeow; I-Hao Su; Kuang-Tse Pan; Pei-Kwei Tsay; Kar-Wai Lui; Yun-Chung Cheung; Andy Shau-Bin Chou
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

3.  Short- and mid-term effects of irreversible electroporation on normal renal tissue: an animal model.

Authors:  J J Wendler; M Porsch; S Hühne; D Baumunk; P Buhtz; F Fischbach; M Pech; D Mahnkopf; S Kropf; A Roessner; J Ricke; M Schostak; U-B Liehr
Journal:  Cardiovasc Intervent Radiol       Date:  2012-08-15       Impact factor: 2.740

4.  Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization.

Authors:  Ajita Deodhar; Timm Dickfeld; Gordon W Single; William C Hamilton; Raymond H Thornton; Constantinos T Sofocleous; Majid Maybody; Mithat Gónen; Boris Rubinsky; Stephen B Solomon
Journal:  AJR Am J Roentgenol       Date:  2011-03       Impact factor: 3.959

5.  Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures.

Authors:  Hongwu Wang; Peter J Littrup; Yunyou Duan; Yanqun Zhang; Huasong Feng; Zhoushan Nie
Journal:  Radiology       Date:  2005-04       Impact factor: 11.105

6.  Irreversible electroporation in a Swine lung model.

Authors:  Damian E Dupuy; Bassam Aswad; Thomas Ng
Journal:  Cardiovasc Intervent Radiol       Date:  2010-12-30       Impact factor: 2.740

7.  Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study.

Authors:  Maciej Pech; Andreas Janitzky; Johann Jacob Wendler; Christof Strang; Simon Blaschke; Oliver Dudeck; Jens Ricke; Uwe-Bernd Liehr
Journal:  Cardiovasc Intervent Radiol       Date:  2010-08-15       Impact factor: 2.740

8.  Microwave ablation of pulmonary malignancies using a novel high-energy antenna system.

Authors:  Mark W Little; Daniel Chung; Philip Boardman; Fergus V Gleeson; Ewan M Anderson
Journal:  Cardiovasc Intervent Radiol       Date:  2012-09-12       Impact factor: 2.740

Review 9.  Irreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go.

Authors:  L J Savic; J Chapiro; B Hamm; B Gebauer; F Collettini
Journal:  Rofo       Date:  2016-04-13

10.  Irreversible Electroporation (IRE): Standardization of Terminology and Reporting Criteria for Analysis and Comparison.

Authors:  Johann J Wendler; Katharina Fischbach; Jens Ricke; Julian Jürgens; Frank Fischbach; Jens Köllermann; Markus Porsch; Daniel Baumunk; Martin Schostak; Uwe-Bernd Liehr; Maciej Pech
Journal:  Pol J Radiol       Date:  2016-02-17
View more
  1 in total

1.  Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF).

Authors:  Emmanuel Ekanem; Vivek Y Reddy; Boris Schmidt; Tobias Reichlin; Kars Neven; Andreas Metzner; Jim Hansen; Yuri Blaauw; Philippe Maury; Thomas Arentz; Philipp Sommer; Ante Anic; Frederic Anselme; Serge Boveda; Tom Deneke; Stephan Willems; Pepijn van der Voort; Roland Tilz; Moritoshi Funasako; Daniel Scherr; Reza Wakili; Daniel Steven; Josef Kautzner; Johan Vijgen; Pierre Jais; Jan Petru; Julian Chun; Laurent Roten; Anna Füting; Andreas Rillig; Bart A Mulder; Arne Johannessen; Anne Rollin; Heiko Lehrmann; Christian Sohns; Zrinka Jurisic; Arnaud Savoure; Stephanes Combes; Karin Nentwich; Melanie Gunawardene; Alexandre Ouss; Bettina Kirstein; Martin Manninger; Jan Eric Bohnen; Arian Sultan; Petr Peichl; Pieter Koopman; Nicolas Derval; Mohit K Turagam; Petr Neuzil
Journal:  Europace       Date:  2022-09-01       Impact factor: 5.486

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.